5 completed, 2 terminated. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 5, Terminated 2 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow mecasermin: new trials by email Literature Review of mecasermin trials Research Report on mecasermin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Anorexia Nervosa on Peak Bone Mass RhIGF-1 with transdermal 17-beta estradiol, Placebo and transdermal 17-beta estradiol - Anorexia Nervosa | Phase 3 | Completed | Massachusetts General Hospital | 75 | 2011-02-01 | 2021-07-13 |
| Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT) NutropinAq (GH) and Increlex (IGF-I), NutropinAq and placebo - Diabetes | Phase 3 | Completed | Karolinska University Hospital | 14 | 2009-10-01 | 2015-04-07 |
| Effect of Increlex® on Children With Crohn Disease rhIGF (Increlex) - Crohn Disease | Phase 2 / Phase 3 | Terminated | Nationwide Children's Hospital | 3 | 2008-10-01 | 2018-03-02 |
| Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency rh IGF-1 (mecasermin) - Growth Disorders | Phase 3 | Terminated | Ipsen | 114 | 2005-11-01 | 2020-08-14 |
| Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency rhIGF-1 (mecasermin) for a period of 86 weeks - Insulin-Like Growth Factor-1 Deficiency, Growth Disorders | Phase 2 / Phase 3 | Completed | Ipsen | 45 | 2005-07-01 | 2020-07-27 |
| Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency rhIGF-1 (mecasermin, Tercica, Inc.) - Growth Disorders, Insulin-Like Growth Factor-1 Deficiency | Phase 3 | Completed | Ipsen | 137 | 2004-03-01 | 2019-09-18 |
| Long-Term Treatment With rhIGF-1 in GHIS mecasermin - Growth Hormone Insensitivity Syndrome | Phase 2 / Phase 3 | Completed | Ipsen | 92 | 1991-05-20 | 2023-07-06 |
Growth Disorders (3) · Anorexia Nervosa (1) · Crohn Disease (1) · Diabetes Mellitus (1) · Dwarfism (1) · Dwarfism, Pituitary (1) · Inflammatory Bowel Diseases (1) · Laron Syndrome (1)
Ipsen (4) · Karolinska University Hospital (1) · Massachusetts General Hospital (1) · Nationwide Children's Hospital (1)
United States (5) · France (1) · Sweden (1)
Charlotte Hoeybye, MD (1) · Dana S. Hardin, MD (1) · Madhusmita Misra, MD, MPH (1) · Sr Vice President, Clinical Development and Medical Affairs (1)
2019 (3)